Remdesivir to be produced in Czech Republic

The drug Remdesivir, which is used to treat patients with severe cases of Covid-19 infection, will soon be manufactured in the Czech Republic, the news site novinky.cz reported on Friday. The Bohemian company Santiago Chemie has reportedly developed its own technology for the drug’s production.

Remdesivir was originally created and manufactured by the American company Gilead Sciences in 2009. The research team which developed it was led by the Czech researcher Tomáš Cihlář.

Large stocks of the drug Remdesivir were bought up by the US government in early July, and the drug will probably not be available to the rest of the world until October. The Czech Republic previously received supplies of the drug for forty people. At present it can only acquire it via EU purchases.